Table 3.
Parameter | Unadjusted Estimate (95% CI), p-value | Adjusted Estimate (95% CI), p-value |
---|---|---|
Age (per decade) | −0.00098 (−0.013, 0.011), p=0.87 | −0.0019 (−0.014, 0.010), p=0.75 |
Female vs. Male | 0.041 (0.0095, 0.073), p=0.011 | 0.047 (0.014, 0.081), p=0.0057 |
African-American vs. Caucasian | 0.0042 (−0.020, 0.029), p=0.74 | −0.018 (−0.044, 0.0079), p=0.17 |
Other/Latino vs. Caucasian | −0.011 (−0.044, 0.022), p=0.52 | −0.011 (−0.043, 0.022), p=0.52 |
Pack Years (per 10 yr increase) | 0.0071 (0.00077, 0.014), p=0.028 | 0.0072 (0.00083, 0.014), p=0.027 |
VL > 75 vs. VL ≤ 75 (copies/mL) | 0.037 (0.014, 0.061), p=0.0017 | 0.035 (0.011, 0.058), p=0.0045 |
Current CD4+ (cells/μL per doubling) | −0.015 (−0.028, −0.0020), p=0.024 | −0.014 (−0.027, −0.0011), p=0.033 |
Analysis includes all 248 HIV-infected participants
Abbreviations: ADMA, asymmetric dimethylarginine; CI, confidence interval; VL, viral load.